Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RNA Interference with chemically modified siRNA.

Hong-Yan Zhang1, Quan Du, Claes Wahlestedt

  • 1Center for Molecular Medicine, Karolinska Institutet, 171 77 Sotckholm, Sweden.

Current Topics in Medicinal Chemistry
|June 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PVN<sup>OXT</sup> regulates acinar cell-mediated inflammatory response via DMV<sup>ACh</sup> projections to the acinar cell.

Journal of neuroinflammation·2026
Same author

Global changes in gene expression and splicing in alcoholic liver disease.

Scientific reports·2026
Same author

Astragaloside IV Ameliorates Diabetic Cardiomyopathy by Suppressing the GNG2/MRAS-ERK Signaling Pathway.

International journal of general medicine·2026
Same author

Beyond locomotion: How specialized motor patterns enable a vertebrate to struggle free from capture.

iScience·2025
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Experimental menopause in 3xTg-AD mice exacerbates metabolic, inflammatory, and osteologic phenotypes aligned with Alzheimer's disease pathology.

Research square·2025
Same journal

Exploration of a Novel Physicochemical Property Space for the Development of Antimalarial Drugs.

Current topics in medicinal chemistry·2026
Same journal

Computational Drug Design of Natural Product-Based Azole Hybrids for Multifactorial Diseases: Success Stories.

Current topics in medicinal chemistry·2026
Same journal

Simulated Natural Nanoparticles in Bai-Hu-Tang Decoction: Preparation, Characterization, Pharmacokinetics, and Antipyretic Effects.

Current topics in medicinal chemistry·2026
Same journal

Dolabellane Diterpenes from the Marine Brown Alga Dictyota dolabellana and their Potential Antiviral Activity.

Current topics in medicinal chemistry·2026
Same journal

Inhibitory Effects of Flavonoids from the Stems and Leaves of Scutellaria baicalensis Georgi on Oligodendrocyte Pyroptosis Induced by Aβ1-42.

Current topics in medicinal chemistry·2026
Same journal

Mechanism of Huangqishihu Decoction in Treating Liver Fibrosis in Rats Model via Regulation of Oxidative Stress and Nrf2 Signaling Pathway.

Current topics in medicinal chemistry·2026
See all related articles

Chemical modifications enhance small interfering RNA (siRNA) for gene silencing. This review focuses on backbone and 2'-ribose modifications to improve in vivo applications and therapeutic potential.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Small interfering RNA (siRNA) is crucial for gene function studies and drug development.
  • Translating in vitro siRNA success to in vivo applications remains challenging.
  • Growing interest in chemical modifications for improved siRNA performance.

Purpose of the Study:

  • To review chemical modifications of siRNA, focusing on backbone and 2"-ribose modifications.
  • To highlight the impact of these modifications on siRNA efficacy and therapeutic potential.

Main Methods:

  • Literature review of chemical modifications applied to siRNA.
  • Focus on backbone modifications and 2"-modifications of the ribose ring.

Main Results:

Related Experiment Videos

  • Various chemical modifications have been explored for siRNA.
  • Backbone and 2"-ribose modifications are key areas of investigation.
  • These modifications aim to overcome challenges in in vivo delivery and therapeutic use.

Conclusions:

  • Chemical modifications are essential for advancing siRNA technology.
  • Further systematic comparisons of modifications are needed for optimized siRNA therapeutics.
  • Continued research into siRNA chemical modifications will drive therapeutic innovation.